cro.directory
← Compare landing

BioDuro-Sundia vs PharmaLegacy Laboratories

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/bioduro-sundia/pharmalegacy

CategoryBioDuro-SundiaPharmaLegacy Laboratories
Listed sitecrocro
SummaryBioDuro-Sundia is a contract research, development, and manufacturing organization (CRDMO) with 30 years of expertise providing integrated drug discovery, development, and manufacturing services from target identification through IND submission.Preclinical CRO with over 1,500 validated in vivo efficacy models spanning 100+ indications in oncology, immunology, inflammation, and bone disease. AAALAC-accredited vivarium with capacity for 30,000 rodents and 350 non-human primates supports IND filings to FDA and CFDA.
Services
  • Discovery Research
  • Target Identification & Validation
  • High-Throughput Screening
  • Computational & In-Silico Drug Discovery
  • Medicinal Chemistry
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • Genetic Toxicology
  • Preclinical In Vitro Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • GLP Toxicology
  • Specialized & Large-Animal Models
  • Preclinical In Vivo Studies
  • Bioanalysis
  • Biomarker Assays
  • Flow Cytometry Services
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Translational Research
  • US FDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Regulatory Affairs
  • Immunogenicity Assays (ADA / NAb)
  • Oncology Specialty Services
  • Immunology & Inflammation Services
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • Safety Pharmacology
  • Specialized & Large-Animal Models
  • Preclinical In Vivo Studies
  • US FDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Translational Research
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Peptide
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
Indications
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Respiratory
  • Oncology
  • Immunology
  • Rare Disease
Locations
  • Headquarters, Irvine, California, United States
  • Headquarters
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.